Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Table shows the odds ratio of reactivity against different cit-Fib peptides and genetic risk allels in RA (HLA-DR SE and PTPN22 risk allele)

From: Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells

  Cit-Fib α 35 Cit-Fib α 216,218 Cit-Fib α 263,271 Cit-Fib α 425,426 Cit-Fib protein
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
SE 1.6 (0.8–3.2) 0.21 0.7 (0.3–1.4) 0.31 1.3 (0.7–2.6) 0.39 1.4 (0.7–2.9) 0.37 2.1 (1.2–3.5) 0.008
PTPN22 1.8 (1–3.1) 0.04 0.6 (0.3–1.2) 0.14 2.0 (1.1–3.4) 0.02 1.6 (0.9–2.8) 0.14 2.1 (1.3–3.5) 0.002
  1. cit-Fib citrullinated fibrinogen, RA rheumatoid arthritis, SE shared epitope